Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
xuanbi antong
- Development stage
- Unknown
- Lead developer
- Guang'anmen Hospital
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Xuanbi Antong is a Traditional Chinese Medicine (TCM) formula developed by the Guang’anmen Hospital of the China Academy of Chinese Medical Sciences (CACMS) for the treatment of coronary heart disease (CHD) and stable angina pectoris. Based on the TCM principle of "resolving phlegm and removing blood stasis," the formula is specifically indicated for patients presenting with phlegm-stasis syndrome. It typically consists of a combination of herbs including *Trichosanthes kirilowii*, *Allium macrostemon*, and *Salvia miltiorrhiza*. Clinical research suggests that Xuanbi Antong improves clinical symptoms, reduces the frequency and duration of angina attacks, and lowers levels of inflammatory biomarkers such as TNF-α and IL-6. It is primarily used as a hospital preparation in China and has been evaluated in various clinical trials to establish its efficacy and safety profile in cardiovascular care.
- Brand names
- Xuanbi Antong
- Other names
- Xuanbi Antong FormulaXuanbi Antong DecoctionXuanbi Antong Granules
02
Targets
TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)NF-κB
Beyond the preview
Go deeper on xuanbi antong.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on xuanbi antong.